CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue	$ 245,913	$ 305,390
Cost of revenue (exclusive of depreciation shown separately below)	13,015	12,497
Gross profit	232,898	292,893
Operating costs and expenses:
Selling and marketing expense	118,541	157,051
General and administrative expense	57,319	85,521
Product development expense	27,087	23,756
Depreciation	9,948	23,849
Total operating costs and expenses	212,895	290,177
Operating income	20,003	2,716
Interest expense	(5,044)	(5,038)
Other income, net	4,828	4,484
Earnings before income taxes	19,787	2,162
Income tax provision	(4,681)	(3,479)
Net earnings (loss)	15,106	(1,317)
Net earnings attributable to noncontrolling interests	0	(314)
Net earnings (loss) attributable to Angi Inc. shareholders	$ 15,106	$ (1,631)
Per share information attributable to Angi Inc. shareholders:
Basic earnings (loss) per share (USD per share)	$ 0.30	$ (0.03)
Diluted earnings (loss) per share (USD per share)	$ 0.30	$ (0.03)
Stock-based compensation expense by function:
Total stock-based compensation expense	$ (2,287)	$ 9,397
Selling and marketing expense
Stock-based compensation expense by function:
Total stock-based compensation expense	636	1,232
General and administrative expense
Stock-based compensation expense by function:
Total stock-based compensation expense	(6,847)	7,193
Product development expense
Stock-based compensation expense by function:
Total stock-based compensation expense	$ 3,924	$ 972